NHPR is continuing to cover the developing story around coronavirus in New Hampshire. Bookmark this page for the latest updates, including case numbers and
NHPR is continuing to cover the developing story around coronavirus in New Hampshire. Bookmark this page for the latest updates, including case numbers and
COVID vaccine information, availability to be posted on state website dashboard
Share This
The Idaho Department of Health and Welfare COVID-19 Tableau dashboard offers users easy access to information regarding the COVID pandemic. IDHW will be launching a similar dashboard tracking the COVID vaccine rollout in the coming days. | Image courtesy of Idaho.gov
BOISE The Idaho Department of Health and Welfare plans to launch a COVID-19 vaccine dashboard on its website soon.
The department is currently operating an interactive dashboard where Idahoans can track information broken down by state and county regarding the COVID pandemic. A similar Tableau dashboard will be launching as soon as this week featuring information pertaining to the vaccine rollout.
NHPR is continuing to cover the developing story around coronavirus in New Hampshire. Bookmark this page for the latest updates, including case numbers and
The Daily Sentinel reached out to Mesa County Public Health to ask some pressing questions about the COVID-19 vaccine. Questions ranged from what the future of vaccine distribution will look like in Mesa County to who should be cautious to receive it.
Question: When will the second phase of vaccines begin?
Answer: Timelines for phases are based on population estimates and are also tied to the amount of vaccine. Using the current prioritization, Phase 2 is estimated to begin this spring.
Q: Who can get the vaccine in the second phase?
A: Phase 2 includes higher-risk individual and other essential workers not covered in Phase 1A & 1B, including: people age 60-69, people age 16-59 with obesity, diabetes, chronic lung disease, significant heart disease, chronic kidney disease, cancer, or are immunocompromised, other essential workers and continuity of local government and adults who received a placebo during a COVID-19 vaccine clinical trial.